Skye Bioscience Net Tangible Assets

Skye Bioscience posts a net tangible assets of $-500K as of June 2026. That compares with $44M in the prior-year period — down 101.1% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Skye Bioscience's net tangible assets was $44M. The latest reading is $-500K — a 101.1% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Net Tangible Assets is one piece of Skye Bioscience's financial statement story. At $-500K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for SKYE's net tangible assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Skye Bioscience's other metric pages and overview cover the third.